Masultab (Amisulpride)

Amisulpride works by selectively blocking dopamine D2 and D3 receptors. At low doses it blocks presynaptic autoreceptors, increasing dopamine release, while at higher doses it blocks postsynaptic receptors, decreasing dopaminergic activity that contributes to psychotic symptoms.

The appropriate dose of Masultab is determined by the prescribing clinician based on the individual patient's condition, response, and tolerability. Dosage may be adjusted over time, and patients should follow the specific instructions provided by their healthcare professional.

Safety data for amisulpride in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any possible risk to the fetus or infant, and decisions should be made in consultation with a qualified healthcare provider.

To order Masultab, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Masultab (amisulpride) is an atypical antipsychotic that primarily targets dopamine D2/D3 receptors, offering a distinct side‑effect profile compared with agents such as risperidone or olanzapine. It may cause fewer metabolic changes but has a higher propensity for extrapyramidal symptoms at certain doses.

Masultab tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Masultab is taken orally, usually with water. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional. Dosing times and frequency are set by the prescriber.

Serious risks include neuroleptic malignant syndrome, tardive dyskinesia, severe hypotension, and agranulocytosis. Patients should seek immediate medical attention if they experience high fever, muscle rigidity, unexplained bruising, persistent low blood pressure, or signs of infection.

Masultab is contraindicated in patients with known hypersensitivity to amisulpride or any excipients in the tablet. It should also be avoided in individuals with a history of severe cardiac arrhythmias, uncontrolled epilepsy, or those currently receiving dopamine‑blocking agents that could cause additive effects.